Amatya R, Jha B, Shrestha S, Adhikari R P, Timsina S
Nepal Med Coll J. 2014 Dec;16(2-4):125-7.
High level aminoglycoside resistance is an established phenomenon in enterococci. With the increasing use of broad spectrum cephalosporins and glycopeptides, vancomycin resistant enterococci are being increasingly reported from different parts of the world. The objective of our study was to determine the prevalence of high level gentamicin resistant (HLAR) enterococci among the clinical isolates in our hospital and to find the minimum inhibitory concentration (MIC) of vancomycin against these isolates. The enterococci isolated over a year (n = 41) were subjected to HLAR screening by disc diffusion and MIC of vancomycin by agar dilution method. HLAR prevalence was 63%. MIC of vancomycin showed none in the resistant range. However, 4 (9.7%) isolates were in the intermediate range heralding the eminent emergence of VRE if adequate control measures are not implemented in time.
高水平氨基糖苷类耐药在肠球菌中是一种既定现象。随着广谱头孢菌素和糖肽类药物的使用增加,世界各地越来越多地报告了耐万古霉素肠球菌。我们研究的目的是确定我院临床分离株中高水平庆大霉素耐药(HLAR)肠球菌的流行情况,并找出万古霉素对这些分离株的最低抑菌浓度(MIC)。对一年内分离出的肠球菌(n = 41)采用纸片扩散法进行HLAR筛查,并用琼脂稀释法测定万古霉素的MIC。HLAR流行率为63%。万古霉素的MIC显示无耐药范围。然而,4株(9.7%)分离株处于中介范围,预示着如果不及时实施适当的控制措施,VRE将显著出现。